CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced the ...
Fluoroquinolones and second-line injectable drugs are the backbone of treatment regimens for multidrug-resistant tuberculosis, and resistance to these drugs defines extensively drug-resistant ...
In a recent study posted to the bioRxiv* pre-print server, a team of researchers used an assay toolset for discovering new transmembrane protease serine 2 (TMPRSS2) inhibiting drug repurposing ...
Optimization of experimental assay design is crucial for the overall success of any drug discovery initiative. The factors that need to be considered include: selection of the most appropriate assay ...
Predicting Bioequivalence During Generic Drug Formulation. Small variations in formulation can affect bioequivalence. However ...
The advent of sophisticated cellular imaging techniques, combined with technological advances in automation and data collection and interpretation, has provided the basis for the development of ...
Predictive Oncology Inc. announced plans to introduce its ChemoFx® drug response assay in Europe, which is aimed at enhancing treatment selection for gynecologic cancers, particularly ovarian cancer.
BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the signing of a global distribution agreement with Beckman Coulter, Inc. to distribute the MyCare™ ...
Hosted on MSN
Popular Cholesterol Drug Recalled For Failing 'Dissolution Specifications', What Does This Mean?
Over 141,000 bottles of popular cholesterol medication, Atorvastatin Calcium Tablets, have been recalled as it "failed dissolution specifications". This means the drugs did not pass a solubility test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results